A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease

Clinical trial NCT06300320 · RECRUITING

Trial details

NCT number: NCT06300320
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Graft Versus Host Disease

Start date: 2024-05-07
Primary completion: 2025-10-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.